Navigation Links
Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
Date:4/15/2008

nts include, but are not limited to, statements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its DARA program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmacopeia's plans to develop PS178990, a product candidate from its SARM program, Pharmacopeia's Phase 1 clinical studies with respect to PS178990, including timing and expected outcomes of such studies, Pharmacopeia's plans to develop PS031291, a product candidate from its chemokine receptor CCR1 program, Pharmacopeia's estimates of the market opportunities for its product candidates, including PS433540, PS178990 and PS031291, Pharmacopeia's ability to raise additional capital, Pharmacopeia's anticipated operating results, financial condition, liquidity and capital resources, Pharmacopeia's ability to successfully perform under its collaborations with Bristol-Myers Squibb, Cephalon, GlaxoSmithKline, Schering-Plough and Wyeth, Pharmacopeia's ability to build its pipeline of novel drug candidates through its own internally-funded drug discovery programs, third party collaborations and in-licensing, Pharmacopeia's expectations concerning the development priorities of its collaborators, their ability to successfully develop compounds and its receipt of milestones and royalties from the collaborations, Pharmacopeia's expectations concerning the legal protections afforded by U.S. and international patent law, Pharmacopeia's ability to pursue the development of new compounds and other business matters without infringing the patent rights of others, additional competition, and changes in economic conditions.

Further information about these and other relevant risks and uncertainties may be found in Pharmacopeia's Reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Pharmacopeia urges you to care
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
2. Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
3. Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
4. Pharmacopeia to Present at BIO CEO & Investor Conference 2008
5. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
6. Pharmacopeia Announces Third Quarter 2007 Financial Results
7. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , 7. Juli 2015 BioClinica®, ... für klinische Studien, gab heute bekannt, dass es ... Unternehmen bei Gewinnung und Erhalt von Patienten übernommen ... MediciGlobal , Ltd. und Access to Patients, ... einen Dienst zum Auffinden von Patienten, die für ...
(Date:7/7/2015)... , July 7, 2015 /PRNewswire/ -- Mindray Medical ... leading developer, manufacturer and marketer of medical devices ... the remaining stake in Wuhan Dragonbio Surgical Implant ... Dragonbio is a domestic medical orthopedic-product ... other surgical products. Prior to today,s announcement, Mindray ...
(Date:7/7/2015)... , July 7, 2015 Oasmia ... drugs within human and veterinary oncology, has filed a ... Exchange Commission, in connection with the proposed public offering ... Market. The number of American Depositary Shares, representing ordinary ... the offering have not yet been determined. An Investor ...
Breaking Medicine Technology:BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2
(Date:7/7/2015)... ... July 07, 2015 , ... ... stores throughout the Southwest, including Giant, Mustang, Sun Dial and Howdy’s, raised ... surpassing their original 2015 fundraising goal by nearly $100,000, to help support ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... MRI services, is debuting their brand new website. The website’s goal is to ... a wider selection of patient tools, including requesting appointments online. , Part of ...
(Date:7/7/2015)... ... July 07, 2015 , ... Greatist today ... website that helps active people find the most fun activities to do with friends. ... for millennials. It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. , ...
(Date:7/7/2015)... ... July 07, 2015 , ... SC&H Group, a leading ... aims to give back to the community through company-wide volunteering efforts. , On an ... dedicate the day to assisting those in need throughout Baltimore and Washington D.C. ...
(Date:7/7/2015)... ... July 07, 2015 , ... Summer is a great time to get outside ... is sharing some safety tips. , Jean Tapley, senior wellness coordinator at Amica, suggests ... , Start slowly. Going from no activity to several hours of ...
Breaking Medicine News(10 mins):Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Amica Insurance Has 7 Summer Safety Tips 2
... Program will celebrate inspiring scientists and their commitment to ... advance global ... to,scientific advancement, Pfizer Inc will launch Think Science Now, a science,awareness ... the mysteries of biology, chemistry and human disease.,A major part of ...
... 24 Americans are experiencing,rising prices on many ... drugs represent one of the fastest-growing medical,expenses. From ... from,$40.3 billion to $200.7 billion, according to a ... To help, Giant is introducing a new way ...
... Devices known as brain-machine interfaces could someday be used ... limbs with just their thoughts. Now, University of Florida ... a way for computerized devices not only to translate ... the brain as it learns. , Instead of simply ...
... Kristen Michelle,Masterson is this year,s Miss Fairfield ... has supervised Kristen,s volunteer,patient care activities over these ... a nurse. "Her compassion for those that are ... one of our pediatric patients or,to our young ...
... June 24 , WHO: Martin Payne, Executive ... Leigh Hocker Radtke, Director, Software Product ... 2:00 PM - ... Inventory Management DESCRIPTION: Medical sales processes are becoming increasingly ...
... Systems Further Royal, Brompton and Harefield NHS Trust,s Leadership ... ... LOUIS, June 24 Stereotaxis, Inc. (Nasdaq:,STXS) announced that British Prime ... of the art electrophysiology lab at,Royal Brompton Hospital in London. The ...
Cached Medicine News:Health News:Pfizer Launches 'Think Science Now' 2Health News:Pfizer Launches 'Think Science Now' 3Health News:Pfizer Launches 'Think Science Now' 4Health News:New Giant Pharmacy Program Offers Relief for Your Family and Your Wallet 2Health News:Researchers develop neural implant that learns with the brain 2Health News:Researchers develop neural implant that learns with the brain 3Health News:Connecticut Hospice Has Miss Fairfield on Its Side 2Health News:Connecticut Hospice Has Miss Fairfield on Its Side 3Health News:SkyeTek to Host Webinar Discussing RFID-Based Solution for Medical Sales Processes Automation 2Health News:London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias 2Health News:London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias 3
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
... offered as 1-piece or modular, in regular ... may be customized with handles of choice ... and flush ports. Many standard patterns are ... affect delivery times. , Please Note: ...
Medicine Products: